Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update detailing the safety, tolerability, and pharmacokinetics assessment of RO7303509 in participants with systemic sclerosis, which …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• RO7303509

Snippet

Sponsor: Genentech, Inc. | Conditions: Systemic Sclerosis | Phase 1 | Status: COMPLETED